Ensysce Biosciences Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS COMPRISING ENZYME-CLEAVABLE AMPHETAMINE PRODRUGS AND INHIBITORS THEREOF".
https://x.com/PatentGrants/status/2084367854472954161https://patentcenter.uspto.gov/applications/17436041/ifw/docs
Ensysce got the official okay from the U.S. patent office to protect a new technology they invented that uses special chemistry to control how amphetamine medicines work in the body. When a company gets a patent, it means they have the legal right to be the only one making that invention for many years, which can help their business if the invention becomes popular.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.